← Open Payments lookup

VALERIE OWEN: Open Payments

NPI 1457809055 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,091 in 70 payments from 14 companies in 2025. Trend: 2023 $1,948 · 2024 $7,915 · 2025 $2,091

Food & beverage: $2,091
CompanyPaymentsAmount
GENZYME CORPORATION9$385
Enterra Medical, Inc.2$340
ABBVIE INC.20$290
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$205
QOL Medical, LLC8$173
Ardelyx, Inc.4$171
Takeda Pharmaceuticals U.S.A., Inc.6$164
Janssen Biotech, Inc.1$90
Madrigal Pharmaceuticals1$74
Regeneron Healthcare Solutions, Inc.3$68

Products named: DUPIXENT, XIFAXAN, Sucraid, IBSRELA, RINVOQ, SKYRIZI, TREMFYA, ENTYVIO.

Industry payments across MD — which companies pay providers there.